Cholesterol replenishment

"Cholesterol replenishment" refers broadly to the set of cellular processes that restore intracellular cholesterol following its depletion. Cells maintain their membrane integrity and support essential functions by tightly regulating cholesterol content through synthesis (via HMG-CoA reductase), uptake (via LDL receptors), efflux (via ABC transporters like ABCA1/ABCG1), storage as esters (via ACAT enzymes), and absorption from dietary sources (via NPC1L1 transporter). Disruption in these processes can lead to diseases such as cardiovascular disease due to excess accumulation or neurodegeneration due to deficiency. While many drugs modulate these pathways—such as statins inhibiting synthesis and ezetimibe blocking absorption—there is no single molecular entity called "cholesterol replenishment"[2][3][4][5][6]. Cholesterol homeostasis involves coordinated regulation among several molecules including enzymes, transporters, receptors, and transcription factors. The term “replenishment” simply denotes restoration after loss—not an actionable drug target itself. If you need information about specific targets involved in this process—such as "Low-density lipoprotein receptor," "HMG-CoA reductase," or "Niemann-Pick C1-like protein 1"—please specify which one you are interested in for structured details.

Mechanisms relate to inhibition/modulation of key proteins in cholesterol handling pathways: - Inhibition of HMG-CoA reductase reduces endogenous synthesis - Inhibition of NPC1L1 blocks intestinal absorption - Upregulation/downregulation of LDL receptors alters cellular uptake